ampicillin sodium

ampicillin sodium

Apo-Ampi (CA), Novo-Ampicillin (CA), Nu-Ampi (CA), Penbritin (CA) (UK), Rimacillin (UK)

Pharmacologic class: Aminopenicillin

Therapeutic class: Anti-infective

Pregnancy risk category B

Action

Destroys bacteria by inhibiting bacterial cell-wall synthesis during microbial multiplication

Availability

Capsules: 250 mg, 500 mg

Oral suspension: 125 mg/5 ml, 250 mg/5 ml

Powder for injection: 125 mg, 250 mg, 500 mg, 1 g, 2 g, 10 g

Indications and dosages

Respiratory tract, skin, and soft-tissue infections caused by Haemophilus influenzae, staphylococci, and streptococci

Adults and children weighing 40 kg (88 lb) or more: 250 to 500 mg I.V. or I.M. q 6 hours

Adults and children weighing less than 40 kg (88 lb): 25 to 50 mg/kg/day I.M. or I.V. in divided doses q 6 to 8 hours

Adults and children weighing more than 20 kg (44 lb): 250 mg P.O. q 6 hours

Children weighing 20 kg (44 lb) or less: 50 mg/kg/day P.O. in divided doses q 6 to 8 hours

Bacterial meningitis caused by Neisseria meningitidis, Escherichia coli, group B streptococci, or Listeria monocytogenes; septicemia caused by Streptococcus species, penicillin G-susceptible staphylococci, enterococci, E. coli, Proteus mirabilis, or Salmonella species

Adults: 150 to 200 mg/kg/day by continuous I.V. infusion or I.M. injection in equally divided doses q 3 to 4 hours, to a maximum dosage of 14 g

Children: 100 to 200 mg/kg/day I.V. in divided doses q 3 to 4 hours

GI or urinary tract infections, including Neisseria gonorrhoeae infection in women

Adults and children weighing more than 40 kg (88 lb): 500 mg I.M. or I.V. q 6 hours

Adults and children weighing 40 kg (88 lb) or less: 50 to 100 mg/kg/day I.M. or I.V. in equally divided doses q 6 to 8 hours

Endocarditis prophylaxis for dental, oral, or upper respiratory tract procedures

Adults: 2 g I.M. or I.V. within 30 minutes before procedure

Children: 50 mg/kg I.V. or I.M. within 30 minutes before procedure

Prevention of bacterial endocarditis before GI or GU surgery or instrumentation

High-risk adults: 2 g I.M. or I.V. with gentamicin 1.5 mg/kg I.M. or I.V. within 30 minutes before procedure. Six hours later, give ampicillin 1 g I.M. or I.V., or amoxicillin 1 g P.O.

High-risk children: 50 mg/kg I.M. or I.V. with 1.5 mg/kg of gentamicin I.M. or I.V. within 30 minutes before procedure; 6 hours later, give ampicillin 25 mg/kg I.M. or I.V. or ampicillin 25 mg/kg P.O.

Moderate-risk adults: 2 g I.M. or I.V. within 30 minutes before procedure Moderate-risk children: 50 mg/kg I.M. or I.V. within 30 minutes before procedure

Prophylaxis for neonatal group B streptococcal disease

Adult women: During labor, loading dose of 2 g I.V.; then 1 g I.V. q 4 hours until delivery

N. gonorrhoeae infections

Adults: Single dose of 3.5 g P.O. given with l g probenecid

Children weighing 40 kg (88 lb) or more: 500 mg I.M. or I.V. q 6 hours

Children weighing less than 40 kg (88 lb): 50 mg/kg/day in divided doses q 6 to 8 hours

Urethritis caused by N. gonorrhoeae (in males)

Adults and children weighing 40 kg (88 lb) or more: 500 mg I.V. or I.M., repeated 8 to 12 hours later

Prophylaxis against sexually transmitted diseases in adult rape victims

Adults: 3.5 g P.O. with l g probenecid as a single dose

Dosage adjustment

• Renal impairment

Contraindications

• Hypersensitivity to penicillins, cephalosporins, imipenem, or other beta-lactamase inhibitors

Precautions

Use cautiously in:

• severe renal insufficiency, infectious mononucleosis

• pregnant or breastfeeding patients.

Administration

• Ask patient about history of penicillin allergy before giving.

• For I.V. use, mix powder with bacteriostatic water for injection in amount listed on label.

• For direct I.V. injection, give over 10 to 15 minutes. Don't exceed 100 mg/minute.

• For intermittent I.V. infusion, mix with 50 to 100 ml of normal saline solution and give over 15 to 30 minutes.

• Change I.V. site every 48 hours.

• Give oral doses 1 hour before or 2 hours after meals.

Adverse reactions

CNS: lethargy, hallucinations, anxiety, confusion, agitation, depression, fatigue, dizziness, seizures

CV: vein irritation, thrombophlebitis, heart failure

EENT: blurred vision, itchy eyes

GI: nausea, vomiting, diarrhea, abdominal pain, enterocolitis, gastritis, stomatitis, glossitis, black "hairy" tongue, furry tongue, oral or rectal candidiasis, pseudomembranous colitis

GU: vaginitis, nephropathy, interstitial nephritis

Hematologic: anemia, eosinophilia, agranulocytosis, hemolytic anemia, leukopenia, thrombocytopenic purpura, thrombocytopenia, neutropenia

Hepatic: nonspecific hepatitis

Musculoskeletal: arthritis exacerbation

Respiratory: wheezing, dyspnea, hypoxia, apnea

Skin: rash, urticaria, fever, diaphoresis

Other: pain at injection site, superinfections, hyperthermia, hypersensitivity reaction, anaphylaxis, serum sickness

Interactions

Drug-drug. Allopurinol: increased risk of rash

Chloramphenicol: synergistic or antagonistic effects

Hormonal contraceptives: decreased contraceptive effect, increased risk of breakthrough bleeding

Probenecid: decreased renal excretion of ampicillin, increased ampicillin blood level

Tetracyclines: reduced bactericidal effect

Drug-diagnostic tests. Conjugated estrone, estradiol, estriol-glucuronide, total conjugated estriols: increased levels in pregnant patients

Granulocytes, hemoglobin, platelets, white blood cells: decreased levels

Coombs' test, urine glucose: false-positive results

Eosinophils: increased count

Drug-food. Any food: reduced ampicillin efficacy

Patient monitoring

• Watch for signs and symptoms of hypersensitivity reaction.

Monitor for seizures when giving high doses.

• Frequently measure patient's temperature and check for signs and symptoms of superinfection, especially oral or rectal candidiasis.

• Monitor for bleeding tendency or hemorrhage.

Patient teaching

• Tell patient to take oral dose with 8 oz of water 1 hour before or 2 hours after a meal.

Instruct patient to immediately report signs and symptoms of hypersensitivity reaction, such as rash, fever, or chills.

• Inform patient that drug lowers resistance to certain other infections. Tell him to report new signs or symptoms of infection, especially in mouth or rectum.

• Advise patient to minimize GI upset by eating small, frequent servings of food and drinking plenty of fluids.

Instruct patient to promptly report unusual bleeding or bruising.

• Tell patient to avoid activities that can cause injury. Advise him to use soft toothbrush and electric razor to avoid gum and skin injury.

• Inform patient taking hormonal contraceptives that drug may reduce contraceptive efficacy. Advise her to use alternative birth control method.

• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, and foods mentioned above.

McGraw-Hill Nurse's Drug Handbook, 7th Ed. Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved
Mentioned in
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.